Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer

NCT05276401 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Request for additional preclinical data.

Conditions

Chronic Diabetic Foot Ulcers

Interventions

DRUG: 5% Bisphosphocin Topical Gel
DRUG: Placebo Topical Gel
DRUG: 10% Bisphosphocin Topical Gel

Sponsor

Lakewood-Amedex Inc

Collaborators

[object Object]
[object Object]